Cargando…
Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis
Background: Non-small-cell lung cancer (NSCLC) remains the leading cause of cancer morbidity and mortality worldwide. In the present study, we identified novel biomarkers associated with the pathogenesis of NSCLC aiming to provide new diagnostic and therapeutic approaches for NSCLC. Methods: The mic...
Autores principales: | Wu, Qiong, Zhang, Bo, Sun, Yidan, Xu, Ran, Hu, Xinyi, Ren, Shiqi, Ma, Qianqian, Chen, Chen, Shu, Jian, Qi, Fuwei, He, Ting, Wang, Wei, Wang, Ziheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526173/ https://www.ncbi.nlm.nih.gov/pubmed/31190860 http://dx.doi.org/10.2147/OTT.S198621 |
Ejemplares similares
-
The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high‐throughput data
por: Zhang, Bo, et al.
Publicado: (2019) -
Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis
por: Chen, Juan, et al.
Publicado: (2019) -
Identification of novel biomarkers and candidate small-molecule drugs in cutaneous melanoma by comprehensive gene microarrays analysis
por: Ma, Jilei, et al.
Publicado: (2021) -
Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data
por: Li, Chengrui, et al.
Publicado: (2021) -
Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
por: Lu, Wei-cheng, et al.
Publicado: (2020)